Director/PDMR Shareholding

Assura PLC

05 June 2023

 

5 June 2023

Assura plc

("the Company")

Notification of transaction by Persons Discharging Managerial Responsibilities ("PDMRs") and connected persons

The Company announces the following transactions in respect of Ordinary Shares of 10 pence each in the Company ("Ordinary Shares"):

·    Jonathan Murphy has acquired 115,000 Ordinary Shares at 48.8p

·    Jayne Cottam's spouse has acquired 62,830 Ordinary Shares at 47.75p

Following the transactions, the total beneficial interest of Jonathan Murphy and Jayne Cottam (including Connected Persons) in the Ordinary Shares is 2,859,515 and 646,248 respectively.

The Notification of Dealing Forms can be found below.

This notification is made in accordance with the Market Abuse Regulation.

Notification of dealing form

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Jonathan Murphy
2	Reason for the notification
a)	Position/status	CEO
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.488 GBP 115,000
d)	Aggregated information -      Aggregated volume -    Price	Aggregate Price Aggregate Volume Aggregate Total £0.488 GBP 115,000 £56,120 GBP
e)	Date of the transaction	02/06/2023
f)	Place of the transaction	XLON

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Jayne Cottam
2	Reason for the notification
a)	Position/status	CFO
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Purchase of shares by spouse
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.4775 GBP 62,830
d)	Aggregated information -      Aggregated volume -    Price	Aggregate Price Aggregate Volume Aggregate Total £0.4775 GBP 62,830 £30,000 GBP
e)	Date of the transaction	02/06/2023
f)	Place of the transaction	XLON

- ENDS -

Assura plc Orla Ball, Company Secretary David Purcell, Investor Relations Director	Tel: [phone] Email: [e-mail]
FGS Global Gordon Simpson James Thompson	Tel: [phone] Email: [e-mail]

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023, Assura's portfolio was valued at £2.7 billion.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

 

END